Radioisotopes: Medical Lifesavers That Congress is Suppressing (Christine Craig, 21st Century Science & Technology) USofA11.Apr.2016
Christine Craig, 21st Century Science & Technology - The use of radioisotopes for the diagnosis and treatment of disease is now a vital part of modern medical practice. The most vulnerable link is the production and supply lines of the medical radioisotope most in demand throughout the world, technetium-99m. The United States is left with no domestic source (2010) for an isotope that is used in more than 30 million diagnostic procedures each year worldwide, and almost 20 million procedures in the United States alone.
Rosatom working in China in nuclear energy, medicine, and science ( Alexander Merten, Lyu Chang) Russia China09.Apr.2016
Alexander Merten, Lyu Chang - Rosatom, the Russian State Atomic Energy Corp, is seeking to hit big in China's nuclear industry with the opening of a regional center headquartered in Beijing - April 2016. The company is not only planning to build more new reactors with its long-standing partner China National Nuclear Corp, but is also expected to expand its business into "non-nuclear activities" such as agriculture, organic chemicals and nuclear medicine. What we are able to provide to our clients is a whole package deal from uranium enrichment, nuclear fuel assembly, construction of nuclear power plants to the fuel reprocessing, and I think that is not something that our rivals can provide.
Curso Básico de Ciencia y Tecnología Nuclear (www.jovenesnucleares.org) SNE Sociedad Nuclear Española Spanish Español Spain07.Apr.2016
Jovenes Nucleares de España, Sociedad Nuclear Española, Curso Básico de Ciencia y Tecnología Nuclear, www.jovenesnucleares.org - El principal objetivo de este libro es acercar a los lectores las nociones generales y los aspectos más relevantes de la ciencia y la tecnología nuclear. Por último se cierra el libro con el análisis sobre el papel que juega la energía nuclear en el ámbito socioeconómico de un país.
John Shanahan, Civil Engineer, initiated a letter to John Holdren, Director of Office of Science and Technology Policy, The White House, dated Feb. 1, 2010. The letter made three recommendations. See his reply. Search keywords "Holdren reply".
1) We believe it’s imperative to accelerate the licensing and building of the kind of reactors now in use, commonly called thermal reactors.
2) Along with the critical need for nuclear energy is the urgent call for the isotopes of nuclear medicine.
3) Development of fourth-generation nuclear reactors will be needed if nuclear power is to expand significantly beyond its present market penetration